REQUEST A DEMO
Total
USD $0.00
Search more companies

Lenis D.o.o. (Slovenia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Lenis D.o.o. Profile Updated: November 04, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

lenis farmacevtika d.o.o is a company that operates as a regional distributor of niche and specialty prescription medicines in the Central and Eastern European (CEE) region, including the Adriatic region. The company is known for supplying unlicensed medicines, addressing drug shortages, and seeking new principals and suppliers of prescription medicines. lenis farmacevtika d.o.o has a direct presence and established field force in several countries in the region and has expanded its coverage through the acquisition and integration of the Medicopharmacia group. Additionally, the company is the lead investor in Niba Labs d.o.o., which provides specialized digital PCR analytical services to companies developing gene therapies.

Headquarters
52 Litostrojska Road
Ljubljana; Osrednjeslovenska; Postal Code: 1000

Contact Details: Purchase the Lenis D.o.o. report to view the information.

Website: http://lenis.si

Basic Information
Total Employees:
Purchase the Lenis D.o.o. report to view the information.
Registered Capital:
Purchase the Lenis D.o.o. report to view the information.
Financial Auditors:
Purchase the Lenis D.o.o. report to view the information.
Incorporation Date:
January 13, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Medicopharmacia, D.o.o.
100%
Lenis D.o.o.
50%
Niba Labs D.o.o.
37.5%
Company Performance
Financial values in the chart are available after Lenis D.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
36.86%
Total operating revenue
36.95%
Operating profit (EBIT)
56.01%
EBITDA
51.95%
Net Profit (Loss) for the Period
65.87%
Total Assets
55.59%
Total Equity
31.47%
Operating Profit Margin (ROS)
1.57%
Net Profit Margin
1.75%
Return on Equity (ROE)
7.54%
Debt/Equity
37.97%
Quick Ratio
-0.52%
Cash Ratio
-0.74%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?